UNLOCKING A NEW SOURCE OF MICROBES TO IMPROVE HUMAN HEALTH
The Food as Medicine™ Company
Solarea Bio is a biotech company in Cambridge MA building solutions for health disorders using bacteria and fungi native to healthy foods to create powerful synergistic, anti-inflammatory microbial assemblages.
Launched at the Illumina Accelerator in 2017, Solarea has built a powerful platform using microbial discovery and genomics to rapidly deliver novel products to address chronic inflammatory conditions.
Solarea Bio is creating a new class of health products by mining the microbes that naturally colonize healthy foods to address inflammatory disorders
Inspired by nature and using computational and experimental approaches, bacteria and fungi are combined with other natural substrates to create functional and specific consortia
Our vision is to create and lead a new way to rapidly discover, develop, and launch commercial products aiding in the management of disorders where other products are not sufficient
News & Press
The NIH/National Institute on Aging has awarded a R01 $3 million grant to study the impact of a medical food developed by Solarea Bio
Hebrew SeniorLife, United States Department of Agriculture (USDA) Human Nutrition Research Center on Aging (HNRCA) at Tufts University, Maine Medical Center Research Institute, and Solarea Bio are grant recipients
Aug 25 2023
Solarea Bio Announces First Close of Series B Financing Round
Solarea Bio announced today a first closing of $15m in a Series B financing led by S2G Ventures with continued participation of Bold Capital Partners, Viking Global Investors, and GG 1978 SICAF SIF.
May 08 2023
Solarea Bio Investigators Receive National Academy of Medicine Healthy Longevity 2022 Quickfire Challenge Award
Work focuses on studying the mycobiome as a novel class of probiotics for the dietary management of inflammation associated with aging.
Sep 29 2022
Solarea first peer-review publication reveals green olives and other fruits and vegetables have vast microbial diversity with the potential to deliver probiotic functionality
Solarea Bio announces its first scientific publication of some of their core research in Scientific Reports, a Nature Portfolio journal. This pilot study describes the microbial diversity known as the “Edible Plant Microbiota” in four commonly consumed items.
Dec 15 2021